67,489 XNAS Volume
XNAS 20 Mar, 2025 2:31 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 31 Dec 2024 | 1,645 | 40,529 (0%) | 0% | 0.9 | 1,415 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 31 Dec 2024 | 3,289 | 34,665 (0%) | 0% | 0.9 | 2,829 | Common Stock |
| Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 31 Dec 2024 | 3,289 | 34,752 (0%) | 0% | 0.9 | 2,829 | Common Stock |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 30 Sep 2024 | 1,645 | 42,174 (0%) | 0% | 0.5 | 767 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 30 Sep 2024 | 3,289 | 37,954 (0%) | 0% | 0.5 | 1,533 | Common Stock |
| Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 30 Sep 2024 | 3,289 | 38,041 (0%) | 0% | 0.5 | 1,533 | Common Stock |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 28 Jun 2024 | 1,645 | 43,819 (0%) | 0% | 0.5 | 821 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 28 Jun 2024 | 3,289 | 41,243 (0%) | 0% | 0.5 | 1,641 | Common Stock |
| Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 28 Jun 2024 | 5,244 | 41,330 (0%) | 0% | 0.5 | 2,617 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Apr 2024 | 32,894 | 45,464 (0%) | 0% | 1.5 | 49,999 | Common Stock |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Apr 2024 | 32,894 | 44,532 (0%) | 0% | 1.5 | 49,999 | Common Stock |
| Angela Rossetti | Director | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Apr 2024 | 32,894 | 200,543 (2%) | 0% | 1.5 | 49,999 | Common Stock |
| Nicolas Gikakis | Director | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Apr 2024 | 32,894 | 46,574 (0%) | 0% | 1.5 | 49,999 | Common Stock |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 29 Mar 2024 | 1,163 | 12,570 (0%) | 0% | 1.7 | 1,954 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 29 Mar 2024 | 1,163 | 11,638 (0%) | 0% | 1.7 | 1,954 | Common Stock |
| Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 29 Mar 2024 | 1,954 | 13,680 (0%) | 0% | 1.7 | 3,283 | Common Stock |
| G. Edward Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 29 Dec 2023 | 1,163 | 13,733 (0%) | 0% | 2.2 | 2,547 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 29 Dec 2023 | 1,163 | 12,801 (0%) | 0% | 2.2 | 2,547 | Common Stock |
| Gikakis Nicolas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 29 Dec 2023 | 1,954 | 15,634 (0%) | 0% | 2.2 | 4,279 | Common Stock |
| Edward Broenniman G. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 29 Sep 2023 | 11,628 | 148,957 (1%) | 0% | 0.2 | 2,674 | Common Stock |
| Gikakis Nicolas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 29 Sep 2023 | 19,541 | 175,873 (1%) | 0% | 0.2 | 4,494 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 29 Sep 2023 | 11,628 | 139,637 (1%) | 0% | 0.2 | 2,674 | Common Stock |
| Nicolas Gikakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 195,414 | 195,414 (2%) | 2% | 0 | Common Stock | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 30 Jun 2023 | 11,628 | 160,585 (1%) | 0% | 0.4 | 4,186 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 30 Jun 2023 | 11,628 | 151,265 (1%) | 0% | 0.4 | 4,186 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 116,279 | 172,213 (1%) | 1% | 0 | Common Stock | |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 116,279 | 162,893 (1%) | 1% | 0 | Common Stock | |
| Angela Rossetti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 116,279 | 167,649 (1%) | 1% | 0 | Common Stock | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 31 Mar 2023 | 3,425 | 55,934 (0%) | 0% | 0.4 | 1,319 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 31 Mar 2023 | 3,425 | 46,614 (0%) | 0% | 0.4 | 1,319 | Common Stock |
| D. Lee Arnold | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 60,620 | 60,620 | - | - | Employee Stock Option (Right to Buy) | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 30 Sep 2022 | 6,849 | 62,784 (0%) | 0% | 0.6 | 3,986 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 30 Sep 2022 | 6,849 | 53,464 (0%) | 0% | 0.6 | 3,986 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 34,247 | 69,633 (0%) | 0% | 0 | Common Stock | |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 34,247 | 60,313 (0%) | 0% | 0 | Common Stock | |
| Angela Rossetti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 51,370 | 51,370 (0%) | 0% | 0 | Common Stock | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 31 Mar 2022 | 2,430 | 35,386 (0%) | 0% | 1.5 | 3,548 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 31 Mar 2022 | 2,430 | 33,642 (0%) | 0% | 1.5 | 3,548 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 31 Mar 2022 | 2,430 | 26,066 (0%) | 0% | 1.5 | 3,548 | Common Stock |
| James B. Frakes | CFO & Sr. VP ? Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 192,600 | 192,600 | - | - | Employee Stock Option (Right to Buy) | |
| Guy Cipriani | Director, Sr. V.P., Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Steven P. Larosa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 30 Jun 2021 | 2,430 | 42,676 (0%) | 0% | 4.9 | 11,931 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 30 Jun 2021 | 2,430 | 40,932 (0%) | 0% | 4.9 | 11,931 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 30 Jun 2021 | 2,430 | 33,356 (0%) | 0% | 4.9 | 11,931 | Common Stock |
| Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 266,888 | 266,888 | - | - | Employee Stock Option (Right to Buy) | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 20,811 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 2.06 per share. | 31 Mar 2021 | 24,295 | 45,106 (0%) | 0% | 2.1 | 50,048 | Common Stock |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 2.06 per share. | 31 Mar 2021 | 24,295 | 43,362 (0%) | 0% | 2.1 | 50,048 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 19,067 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Charles J. Fisher | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 19,569 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 2.06 per share. | 31 Mar 2021 | 24,295 | 35,786 (0%) | 0% | 2.1 | 50,048 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 11,491 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Guy Cipriani | Director, Sr. V.P., Chief Bus. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 31 Mar 2021 | 2,575 | 17,901 (0%) | 0% | 2.0 | 5,227 | Common Stock |
| Guy Cipriani | Director, Sr. V.P., Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 120,883 | 120,883 | - | - | Employee Stock Option (Right to Buy) | |
| Steven P. Larosa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 120,883 | 120,883 | - | - | Employee Stock Option (Right to Buy) | |
| Chetan S. Shah | Director | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 17 Dec 2020 | 21,101 | 22,392 (0%) | 0% | 2.1 | 44,523 | Common Stock |
| Chetan S. Shah | Director | Sale of securities on an exchange or to another person at price $ 2.10 per share. | 17 Dec 2020 | 5,417 | 16,975 (0%) | 0% | 2.1 | 11,358 | Common Stock |
| Chetan S. Shah | Director | Sale of securities on an exchange or to another person at price $ 2.09 per share. | 17 Dec 2020 | 334 | 16,641 (0%) | 0% | 2.1 | 699 | Common Stock |
| Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2020 | 239,122 | 239,122 | - | - | Employee Stock Option (Right to Buy) | |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 25,961 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 24,217 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 24,719 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 43,493 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 30 Sep 2020 | 2,389 | 23,051 (0%) | 0% | 1.3 | 3,225 | Common Stock |
| Edward G. Broenniman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 27,421 (0%) | 0% | 2.0 | 4,850 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 25,677 (0%) | 0% | 2.0 | 4,850 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 26,179 (0%) | 0% | 2.0 | 4,850 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 44,953 (0%) | 0% | 2.0 | 4,850 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 30 Jun 2020 | 2,389 | 24,511 (0%) | 0% | 2.0 | 4,850 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 23,893 | 29,810 (0%) | 0% | 0 | Common Stock | |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 929 | 28,350 (0%) | 0% | 0 | Common Stock | |
| James B. Frakes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 140,472 | 140,472 | - | - | Employee Stock Option (right to buy) | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 23,893 | 28,066 (0%) | 0% | 0 | Common Stock | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 929 | 26,606 (0%) | 0% | 0 | Common Stock | |
| Charles J. Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 929 | 27,108 (0%) | 0% | 0 | Common Stock | |
| Charles J. Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 23,893 | 28,568 (0%) | 0% | 0 | Common Stock | |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 23,893 | 47,342 (0%) | 0% | 0 | Common Stock | |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 929 | 45,882 (0%) | 0% | 0 | Common Stock | |
| Timothy C. Rodell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 202,280 | 202,280 | - | - | Employee Stock Option (right to buy) | |
| Guy Cipriani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 929 | 25,440 (0%) | 0% | 0 | Common Stock | |
| Guy Cipriani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 23,893 | 26,900 (0%) | 0% | 0 | Common Stock | |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.52 per share. | 31 Mar 2020 | 244 | 4,173 (0%) | 0% | 1.5 | 371 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.52 per share. | 31 Mar 2020 | 244 | 4,675 (0%) | 0% | 1.5 | 371 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.52 per share. | 31 Mar 2020 | 244 | 23,449 (0%) | 0% | 1.5 | 371 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.52 per share. | 31 Mar 2020 | 244 | 3,007 (0%) | 0% | 1.5 | 371 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Dec 2019 | 246 | 4,417 (0%) | 0% | 0.8 | 208 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Dec 2019 | 246 | 4,919 (0%) | 0% | 0.8 | 208 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Dec 2019 | 246 | 23,693 (0%) | 0% | 0.8 | 208 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Dec 2019 | 246 | 3,251 (0%) | 0% | 0.8 | 208 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.24 per share. | 30 Sep 2019 | 3,684 | 69,944 (0%) | 0% | 0.2 | 866 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.24 per share. | 30 Sep 2019 | 3,684 | 77,469 (0%) | 0% | 0.2 | 866 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.24 per share. | 30 Sep 2019 | 3,684 | 359,075 (3%) | 0% | 0.2 | 866 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.24 per share. | 30 Sep 2019 | 3,684 | 52,444 (0%) | 0% | 0.2 | 866 | Common Stock |
| Sabrina Martucci Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 30 Jun 2019 | 3,684 | 73,628 (0%) | 0% | 0.4 | 1,363 | Common Stock |
| Charles J. Fisher | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 30 Jun 2019 | 3,684 | 81,153 (0%) | 0% | 0.4 | 1,363 | Common Stock |
| Chetan S. Shah | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 30 Jun 2019 | 3,684 | 362,759 (3%) | 0% | 0.4 | 1,363 | Common Stock |
| Guy Cipriani | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 30 Jun 2019 | 3,684 | 56,128 (0%) | 0% | 0.4 | 1,363 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.25 per share. | 30 Apr 2019 | 129 | 2,836 (0%) | 0% | 11.2 | 1,451 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.93 per share. | 30 Apr 2019 | 115 | 2,608 (0%) | 0% | 3.9 | 452 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.30 per share. | 30 Apr 2019 | 113 | 2,723 (0%) | 0% | 3.3 | 373 | Common Stock |
| Edward G. Broenniman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 36,842 | 88,747 (0%) | 2% | 0 | Common Stock | |
| Sabrina Martucci Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 36,842 | 36,842 | - | - | Restricted Stock Units (RSU) | |
| Charles J. Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 36,842 | 36,842 | - | - | Restricted Stock Units (RSU) | |
| Chetan S. Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 36,842 | 36,842 | - | - | Restricted Stock Units (RSU) | |
| Guy Cipriani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 36,842 | 36,842 | - | - | Restricted Stock Units (RSU) | |
| James B. Frakes | Chief Financial Officer | 31 Mar 2019 | 4,529 | 44,470 (0%) | 0% | 1.0 | 4,303 | Common Stock | |
| James B. Frakes | Chief Financial Officer | 31 Mar 2019 | 1,922 | 48,999 (0%) | 0% | 1.4 | 2,691 | Common Stock | |
| James B. Frakes | Chief Financial Officer | 31 Mar 2019 | 4,047 | 50,921 (0%) | 0% | 1.3 | 5,261 | Common Stock | |
| James B. Frakes | Chief Financial Officer | 31 Mar 2019 | 1,718 | 54,968 (0%) | 0% | 1.0 | 1,684 | Common Stock | |
| Sabrina Martucci Johnson | Director | 31 Mar 2019 | 3,573 | 40,470 (0%) | 0% | 0.9 | 3,394 | Common Stock | |
| Sabrina Martucci Johnson | Director | 31 Mar 2019 | 3,573 | 47,616 (0%) | 0% | 1.2 | 4,216 | Common Stock | |
| Sabrina Martucci Johnson | Director | 31 Mar 2019 | 3,573 | 44,043 (0%) | 0% | 1.3 | 4,645 | Common Stock | |
| Charles J. Fisher | Director | 31 Mar 2019 | 3,573 | 51,568 (0%) | 0% | 1.3 | 4,645 | Common Stock | |
| Charles J. Fisher | Director | 31 Mar 2019 | 3,573 | 55,141 (0%) | 0% | 1.2 | 4,216 | Common Stock | |
| Charles J. Fisher | Director | 31 Mar 2019 | 3,573 | 47,995 (0%) | 0% | 0.9 | 3,394 | Common Stock | |
| Chetan S. Shah | Director | 31 Mar 2019 | 3,573 | 336,747 (3%) | 0% | 1.2 | 4,216 | Common Stock | |
| Chetan S. Shah | Director | 31 Mar 2019 | 3,573 | 329,601 (3%) | 0% | 0.9 | 3,394 | Common Stock | |
| Chetan S. Shah | Director | 31 Mar 2019 | 3,573 | 333,174 (3%) | 0% | 1.3 | 4,645 | Common Stock | |
| Guy Cipriani | Director | 31 Mar 2019 | 5,105 | 28,075 (0%) | 0% | 1.3 | 6,637 | Common Stock | |
| Guy Cipriani | Director | 31 Mar 2019 | 5,105 | 22,970 (0%) | 0% | 1.0 | 4,850 | Common Stock | |
| Guy Cipriani | Director | 31 Mar 2019 | 5,105 | 33,180 (0%) | 0% | 1.2 | 6,024 | Common Stock | |
| Timothy C. Rodell | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2018 | 552,625 | 552,625 | - | - | Employee Stock Option (Right to Buy) | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 31 Oct 2018 | 18,683 | 212,370 (1%) | 0% | 1.0 | 19,430 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | 31 Oct 2018 | 39,625 | 279,064 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | 31 Oct 2018 | 3,250 | 22,435 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 31 Oct 2018 | 1,768 | 20,358 (0%) | 0% | 1.0 | 1,839 | Common Stock |
| James B. Frakes | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 31 Jul 2018 | 1,562 | 16,345 (0%) | 0% | 1.2 | 1,921 | Common Stock |
| James B. Frakes | Chief Financial Officer | 31 Jul 2018 | 3,250 | 49,789 | - | - | Restricted Stock Units | ||
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.23 per share. | 31 Jul 2018 | 1,688 | 60,701 (0%) | 0% | 1.2 | 2,076 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 31 Jul 2018 | 4,015 | 56,686 (0%) | 0% | 1.2 | 4,738 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | 31 Jul 2018 | 39,625 | 318,689 | - | - | Restricted Stock Units | ||
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 31 Jul 2018 | 18,683 | 193,687 (1%) | 0% | 1.2 | 22,980 | Common Stock |
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 31 Jul 2018 | 1,797 | 18,590 (0%) | 0% | 1.2 | 2,210 | Common Stock |
| Rodney S. Kenley | Director, President | 31 Jul 2018 | 3,250 | 25,685 | - | - | Restricted Stock Units | ||
| Charles J. Fisher | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2018 | 26,799 | 79,990 | - | - | Restricted Stock Units | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 26,799 | 79,536 (0%) | 0% | 0 | Common Stock | |
| James B. Frakes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 22,971 | 62,389 (0%) | 0% | 0 | Common Stock | |
| Sabrina Martucci Johnson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 26,799 | 51,189 (0%) | 0% | 0 | Common Stock | |
| Guy Cipriani | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 38,285 | 38,285 (0%) | 0% | 0 | Common Stock | |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 30 Apr 2018 | 1,922 | 39,418 (0%) | 0% | 1.3 | 2,575 | Common Stock |
| James A. Joyce | Director, CEO, Secretary | 30 Apr 2018 | 39,625 | 358,314 | - | - | Restricted Stock Units | ||
| James A. Joyce | Director, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 30 Apr 2018 | 18,771 | 175,004 (0%) | 0% | 1.3 | 25,153 | Common Stock |
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.34 per share. | 30 Apr 2018 | 1,596 | 16,793 (0%) | 0% | 1.3 | 2,139 | Common Stock |
| Rodney S. Kenley | Director, President | 30 Apr 2018 | 3,250 | 28,935 | - | - | Restricted Stock Units | ||
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2018 | 26,799 | 340,320 (1%) | 0% | 0 | Common Stock | |
| Chetan S. Shah | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 31 Mar 2018 | 7,447 | 313,521 (1%) | 0% | 1.2 | 8,862 | Common Stock |
| Sabrina Martucci Johnson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2018 | 40,650 | 40,650 (0%) | 0% | 0 | Common Stock | |
| Sabrina Martucci Johnson | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 06 Feb 2018 | 16,260 | 24,390 (0%) | 0% | 1.2 | 19,349 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 31 Jan 2018 | 1,857 | 41,340 (0%) | 0% | 1.5 | 2,786 | Common Stock |
| James A. Joyce | Director, CEO, Secretary | 31 Jan 2018 | 39,625 | 397,939 | - | - | Restricted Stock Units | ||
| James A. Joyce | Director, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 31 Jan 2018 | 16,979 | 156,233 (0%) | 0% | 1.5 | 25,469 | Common Stock |
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 31 Jan 2018 | 1,596 | 15,197 (0%) | 0% | 1.5 | 2,394 | Common Stock |
| Rodney S. Kenley | Director, President | 31 Jan 2018 | 3,250 | 32,185 | - | - | Restricted Stock Units | ||
| Charles J. Fisher | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 31 Dec 2017 | 10,638 | 42,553 (0%) | 0% | 1.1 | 12,127 | Common Stock |
| Charles J. Fisher | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2017 | 26,799 | 58,714 (0%) | 0% | 0 | Common Stock | |
| Charles J. Fisher | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 31 Dec 2017 | 10,638 | 31,915 (0%) | 0% | 1.2 | 12,659 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2017 | 16,000 | 139,254 (0%) | 0% | 0 | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2017 | 37,234 | 53,666 | - | - | Restricted Stock Units | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2017 | 37,234 | 53,666 | - | - | Restricted Stock Units | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.98 per share. | 30 Oct 2017 | 19,079 | 155,254 (1%) | 0% | 1.0 | 18,697 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | 30 Oct 2017 | 39,625 | 437,564 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | 30 Oct 2017 | 3,250 | 35,435 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.98 per share. | 30 Oct 2017 | 1,768 | 13,601 (0%) | 0% | 1.0 | 1,733 | Common Stock |
| James B. Frakes | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share. | 11 Oct 2017 | 1,565 | 10,497 (0%) | 0% | 1.1 | 1,784 | Common Stock |
| James B. Frakes | Chief Financial Officer | 11 Oct 2017 | 3,250 | 39,818 | - | - | Restricted Stock Units | ||
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share. | 11 Oct 2017 | 19,079 | 136,175 (0%) | 0% | 1.1 | 21,750 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | 11 Oct 2017 | 39,625 | 477,189 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | 11 Oct 2017 | 3,250 | 38,685 | - | - | Restricted Stock Units | ||
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share. | 11 Oct 2017 | 1,768 | 11,833 (0%) | 0% | 1.1 | 2,016 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 28 Sep 2017 | 1,685 | 43,197 (0%) | 0% | 1.1 | 1,921 | Common Stock |
| James B. Frakes | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2017 | 1,594 | 43,068 | - | - | Restricted Stock Units | |
| James B. Frakes | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.23 per share. | 01 May 2017 | 1,594 | 8,932 (0%) | 0% | 2.2 | 3,555 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.23 per share. | 01 May 2017 | 19,079 | 117,096 (1%) | 0% | 2.2 | 42,546 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 May 2017 | 19,079 | 516,814 | - | - | Restricted Stock Units | |
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.23 per share. | 01 May 2017 | 1,797 | 10,065 (0%) | 0% | 2.2 | 4,007 | Common Stock |
| Rodney S. Kenley | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2017 | 1,797 | 41,935 | - | - | Restricted Stock Units | |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.23 per share. | 30 Apr 2017 | 1,656 | 44,882 (0%) | 0% | 2.2 | 3,693 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.28 per share. | 07 Feb 2017 | 98,107 | 98,107 (1%) | 1% | 4.3 | 419,898 | Common Stock |
| James A. Joyce | Director, Chairman, CEO, Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Feb 2017 | 98,107 | 535,893 | - | - | Restricted Stock Units | |
| Rodney S. Kenley | Director, President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Feb 2017 | 8,268 | 43,732 | - | - | Restricted Stock Units | |
| Rodney S. Kenley | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.28 per share. | 07 Feb 2017 | 8,268 | 8,268 (0%) | 0% | 4.3 | 35,387 | Common Stock |
| James B. Frakes | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.28 per share. | 31 Jan 2017 | 5,662 | 46,538 (0%) | 0% | 4.3 | 24,233 | Common Stock |
| Edward G. Broenniman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 1,368 | 2,736 | - | - | Restricted Stock Units | |
| Edward G. Broenniman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 821 | 13,861 | - | - | Common Stock | |
| Franklyn S. Barry | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 1,368 | 2,736 | - | - | Restricted Stock Units | |
| Franklyn S. Barry | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 821 | 10,340 | - | - | Common Stock | |
| Chetan S. Shah | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 1,368 | 2,736 | - | - | Restricted Stock Units | |
| Chetan S. Shah | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2016 | 1,368 | 280,998 | - | - | Common Stock | |
| Edward G. Broenniman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 4,104 | - | - | Restricted Stock Units | |
| Edward G. Broenniman | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2016 | 4,931 | 13,040 | - | - | Common Stock | |
| Edward G. Broenniman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 17,971 | - | - | Common Stock | |
| Franklyn S. Barry | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2016 | 4,931 | 9,519 | - | - | Common Stock | |
| Franklyn S. Barry | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 14,450 | - | - | Common Stock | |
| Franklyn S. Barry | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 4,104 | - | - | Restricted Stock Units | |
| Chetan S. Shah | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 279,630 | - | - | Common Stock | |
| Chetan S. Shah | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2016 | 12,328 | 4,104 | - | - | Restricted Stock Units | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2016 | 2,000 | 2,000 | - | - | Common Stock | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2016 | 2,000 | 72,000 | - | - | Common Stock | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2016 | 2,000 | 70,000 | - | - | Common Stock | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2016 | 2,000 | 74,000 | - | - | Common Stock | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Aug 2016 | 2,000 | 2,000 | - | - | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 16,432 | 16,432 | - | - | Restricted Stock Units | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 634,000 | 634,000 | - | - | Restricted Stock Units | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 16,432 | 16,432 | - | - | Restricted Stock Units | |
| James B. Frakes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 52,000 | 52,000 | - | - | Restricted Stock Units | |
| Rodney Kenley | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 52,000 | 52,000 | - | - | Restricted Stock Units | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2016 | 16,432 | 16,432 | - | - | Restricted Stock Units | |
| Chetan S. Shah | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Oct 2014 | 666,667 | 4,835,316 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 666,667 | 5,501,983 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Oct 2014 | 333,333 | 5,168,650 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 333,333 | 5,501,983 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Oct 2014 | 1,111,111 | 4,390,872 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 1,111,111 | 5,501,983 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 666,667 | 11,920,633 | - | - | Common Stock | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 333,333 | 12,253,966 | - | - | Common Stock | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2014 | 1,111,111 | 13,365,077 | - | - | Common Stock | |
| Chetan S. Shah | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2014 | 220,349 | 0 | - | - | 10% Convertible Note | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2014 | 1,251,983 | 5,501,983 | - | - | Common Stock Purchase Warrant | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2014 | 2,503,966 | 11,253,966 | - | - | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 184,211 | 2,480,291 | - | - | Stock Options (right to buy) | |
| James A. Joyce | Director, CHAIRMAN, CEO, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 1,500,000 | 15,588,243 | - | - | Stock Options (right to buy) | |
| Richard H. Tullis | Director, VP, CHIEF SCIENCE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 50,000 | 3,167,175 | - | - | Stock Options (right to buy) | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 184,211 | 2,336,116 | - | - | Stock Options (right to buy) | |
| James B. Frakes | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 250,000 | 1,250,000 | - | - | Stock Options (right to buy) | |
| Rodney Kenley | Director, PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 250,000 | 1,750,000 | - | - | Stock Options (right to buy) | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2014 | 184,211 | 560,235 | - | - | Stock Options (right to | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2014 | 426,829 | 2,296,080 | - | - | Stock options (right to buy) | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2014 | 426,829 | 2,151,908 | - | - | Stock options (right to buy) | |
| Philip Ward | Other | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2014 | 182,927 | 555,953 | - | - | Stock Options (right to buy) | |
| Chetan S. Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2014 | 376,024 | 376,024 | - | - | Stock options (right to buy) | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2012 | 460,526 | 1,869,251 | - | - | Stock options (right to buy) | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2012 | 460,526 | 1,725,076 | - | - | Stock options (right to buy) | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2012 | 2,000,000 | 14,088,243 | - | - | Stock Options (right to buy) | |
| James A. Joyce | Director, Chairman, CEO, Secretary | Other type of transaction at price $ 0.00 per share. | 26 Jun 2012 | 600,000 | 3,800,000 | - | - | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2010 | 600,000 | 1,414,225 | - | - | Stock options (right to buy) | |
| James A. Joyce | Director, Chairman, Pres, CEO, Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2010 | 2,500,000 | 12,088,243 | - | - | Stock options (right to buy) | |
| Richard H. Tullis | Director, VP, Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2010 | 1,000,000 | 2,897,175 | - | - | Stock Options (right to buy) | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2010 | 500,000 | 1,266,417 | - | - | Stock Options (right to buy) | |
| James A. Joyce | Director, Chairman, Pres, CEO, CFO, Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2010 | 4,000,000 | 4,400,000 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2010 | 11,500 | 122,893 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2010 | 11,900 | 110,993 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2010 | 4,400 | 106,593 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 11,000 | 371,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 11,400 | 359,974 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 11,500 | 348,474 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 11,900 | 336,574 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 12,000 | 324,574 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 12,500 | 312,074 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 12,500 | 299,574 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 12,500 | 287,074 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2010 | 4,900 | 282,174 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 6,700 | 475,474 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,000 | 468,474 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,100 | 461,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,200 | 454,174 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,400 | 446,774 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,700 | 439,074 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,700 | 431,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 8,000 | 423,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 9,000 | 414,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 10,000 | 404,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,000 | 393,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,000 | 382,374 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 6,700 | 249,893 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,000 | 242,893 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,100 | 235,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,200 | 228,593 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,400 | 221,193 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,700 | 213,493 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 7,700 | 205,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 8,000 | 197,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 9,000 | 188,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 10,000 | 178,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,000 | 167,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,000 | 156,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,000 | 145,793 | - | - | Common Stock | |
| Franklyn S. Barry | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Mar 2010 | 11,400 | 134,393 | - | - | Common Stock | |
| James A. Joyce | Director, Chair., Pres., CEO, CFO, Sec., Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Dec 2009 | 300,000 | 400,000 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Nov 2009 | 100,000 | 482,174 | - | - | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2008 | 500,000 | 1,020,050 | - | - | Stock Options (right to buy) | |
| James A. Joyce | Director, Chairman, Pres, CEO, CFO, Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2008 | 2,000,000 | 9,588,243 | - | - | Stock Options (right to buy) | |
| Richard H. Tullis | Director, VP, Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2008 | 750,000 | 2,764,350 | - | - | Stock Options (right to buy) | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2008 | 500,000 | 766,417 | - | - | Stock Options (right to buy) | |
| Richard H. Tullis | Director, VP, Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2008 | 468,750 | 526,750 | - | - | Common Stock | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2008 | 446,300 | 582,174 | - | - | Common Stock | |
| James A. Joyce | Director, Chief Executive Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2008 | 100,000 | 700,000 | - | - | Common Stock | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2008 | 250,000 | 264,500 | - | - | Stock Option | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2008 | 250,000 | 256,593 | - | - | Common Stock | |
| James A. Joyce | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2007 | 2,500,000 | 7,588,243 | - | - | Stock Option | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 5,500 | 230,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 5,000 | 225,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 3,000 | 222,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 25,000 | 197,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 11,500 | 185,874 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 36,300 | 149,574 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 10,000 | 139,574 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2007 | 3,700 | 135,874 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Mar 2006 | 5,000 | 250,874 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Mar 2006 | 5,000 | 245,874 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Mar 2006 | 2,500 | 243,374 | - | - | Common Stock | |
| Edward G. Broenniman | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Mar 2006 | 7,500 | 235,874 | - | - | Common Stock | |
| James A. Joyce | Director, CEO - SECRETARY, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2005 | 2,857,143 | 5,088,243 | - | - | Stock Options | |
| James A. Joyce | Director, CEO - SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2005 | 250,000 | 2,231,100 | - | - | Stock Options | |
| Edward G. Broenniman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2005 | 545,225 | 550,725 | - | - | Stock Options | |
| James A. Joyce | Director, Chief Executive Officer, Secre | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2005 | 2,231,100 | 2,481,100 | - | - | Stock Options | |
| Richard H. Tullis | Director, Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2005 | 1,734,350 | 1,989,350 | - | - | Stock Options | |
| Franklyn S. Barry | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2005 | 545,225 | 957,725 | - | - | Stock Options | |
| Calvin M. Leung | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2005 | 339,400 | 349,400 | - | - | Stock Options |